London Genetics
The deal gives Quintiles access to PGT’s genomic data-analysis technology, and is in line with Quintiles' ongoing efforts to expand its pharmacogenomics research capabilities.
After inking a similar deal with Dako earlier in the month, Quintiles announced this week that it would collaborate with pharmacogenetics firm London Genetics to provide personalized medicine services to drug developers. Financial terms of the deal were not disclosed.
Quintiles, London Genetics Ink PGx Services Pact
The companies will provide biomarker and assay development services and consulting to biopharmas through a new alliance.
London Genetics, Astrimmune to Seek PGx Markers for Investigational Pancreatic Cancer Vaccine
Premium
A grant from the UK's East Midlands Development Agency will facilitate the search for a biomarker to personalize Astrimmune's pancreatic cancer vaccine.